View Older Stories View More Recent Stories
-
Roth Capital Remains Bullish Following Ligand Pharma's (LGND) Supply Agreement with Gilead (GILD)
-
Pre-Open Stock Movers 12/31: (PSTI) (PBMD) (ANFI) Higher; (AVXL) (AEZS) Lower (more...)
-
Lucas Energy (LEI) to Acquire Producing Properties and Undeveloped Acreage; Includes Mid-Continent Region
-
Lucas Energy Announces Entry Into Mid-Continent With Agreement To Acquire Hunton Properties
-
Prima BioMed Ltd (PBMD) Gains as Analyst Sees Over 400% Upside
-
After-Hours Stock Movers 12/30: (PBMD) (CMRX) Higher; (AEZS) Lower (more...)
-
Roth Capital Starts Prima Biomed (PBMD) at Buy; $6 PT
-
Roth Capital Starts Tetralogic Pharmaceuticals (TLOG) at Buy; $5 PT
-
Lilis Energy to Merge With Brushy Resources
-
Hemostemix Joins the OTCQX Marketplace in the United States
-
OTC Markets Group Welcomes Hemostemix to OTCQX
-
Aduro Biotech (ADRO) Added to Focus List at Roth Capital
-
Iradimed Corp. (IRMD) Closes $29.1M Secondary Offering of Common Stock
-
IRADIMED CORPORATION Announces Closing of $29.1 Million Secondary Offering of Common Stock and Exercise of Overallotment Option
-
Notable Analyst Rating Changes 12/22: (SAVE) (FINL) (BAH) Upgraded; (CMG) (SCSS) (PHM) Downgraded
-
Roth Capital Starts Fenix Parts (FENX) at Buy
-
Roth Capital Reiterates Buy Following Neogen Corp's (NEOG) Mixed 2Q Results
-
Roth Capital Starts Fibrocell Science (FCSC) at Buy
-
Roth Capital Starts Etsy (ETSY) at Sell
-
Roth Capital Starts Marchex (MCHX) at Buy
-
Sorl Auto Parts (SORL) Forms Special Committee to Evaluate 'Go Private' Offer
-
SORL Auto Parts Announces Formation of a Special Committee to Evaluate Non-Binding Proposal
-
Lion Biotech's (LBIO) Collaboration with MedImmune (AZN) Indicates Increasing TIL Interest - Roth Capital
-
Roth Affirms Horizon Global (HZN) at 'Buy' Following Investor Meetings; Facility Consolidation on Schedule
-
Iradimed Corp. (IRMD) Prices 1.04M Common Secondary Offering at $24.25/Share
-
IRADIMED CORPORATION Announces Pricing of Secondary Offering of Common Stock
-
Roth Positive on Ligand's (LGND) Move to Acquire OMT; Bumps PT to $146
-
Uranium Resources (URRE) Announces $1M Equity Raise
-
Uranium Resources Announces $1.0 Million Funding
-
Iradimed Corp. (IRMD) CEO to Offer Stock
-
IRADIMED CORPORATION Announces Proposed Secondary Offering of Common Stock
-
Roth Capital Starts Upland Software (UPLD) at Buy
-
Hydrogenics Announces Closing of Underwritten Public Offering and Full Exercise of Over-Allotment Option
-
Unusual 11 Mid-Day Movers 12/16: (ACST) (JRJC) (ENPH) Higher; (ACI) (RPXC) (MG) Lower
-
Notable Analyst Rating Changes 12/16: (CHRW) (BYD) (BEAV) Upgraded; (OREX) (LPT) (KMT) Downgraded
-
Roth Capital Upgrades ReneSola Ltd. (SOL) to Buy
-
Roth Capital Upgrades JA Solar Holdings Co., Ltd. (JASO) to Buy
-
UPDATE: BTC Renewal is Material Positive for Darling Ingredients (DAR) Joint Venture; Roth Affirms at 'Buy'
-
Roth Capital Upgrades Enphase Energy (ENPH) to Buy
-
SolarCity (SCTY) PT Raised to $65 at Roth Capital Following Analyst Day
-
Spark Therapeutics (ONCE) Prices 3M Common Offering at $47/Share
-
Spark Therapeutics Announces Pricing of Public Offering
-
Facebook's (FB) 'Professional Services' Testing May Challenge Yelp (YELP) Prospects - Roth Capital Reiterates Sell
-
Roth Capital Cuts Price Target on Crossroads Systems (CRDS) Following Mixed 4Q Results
-
Spark Therapeutics (ONCE) Announces 3M Common Stock Offering
-
Spark Therapeutics Announces Launch of Public Offering
-
Roth Reaffirms Canadian Solar (CSIQ) at 'Buy' Following Meetings with Management; 2016 Shaping up Well
-
Viralytics Completes $28 million Placement -- SPP to Follow
-
XPEL to Attend Third Annual ROTH New Industrials Corporate Access Day
-
Hydrogenics (HYGS) Prices 2.13M Common Stock Offering at $7.75/Share

